Alpine Immune Sciences inks $91m private placement

Alpine Immune Sciences, a developer of treatments for cancer and autoimmune/inflammatory diseases, has agreed to raise about $91 million in a private placement.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this